Annika Lindstén

522 total citations
20 papers, 319 citations indexed

About

Annika Lindstén is a scholar working on Psychiatry and Mental health, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Annika Lindstén has authored 20 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Psychiatry and Mental health, 5 papers in Pathology and Forensic Medicine and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Annika Lindstén's work include Migraine and Headache Studies (7 papers), Trigeminal Neuralgia and Treatments (5 papers) and Cerebrovascular and Carotid Artery Diseases (3 papers). Annika Lindstén is often cited by papers focused on Migraine and Headache Studies (7 papers), Trigeminal Neuralgia and Treatments (5 papers) and Cerebrovascular and Carotid Artery Diseases (3 papers). Annika Lindstén collaborates with scholars based in Denmark, United States and South Africa. Annika Lindstén's co-authors include Mette Krog Josiassen, Anders Ettrup, Roger Cady, Howard A. Rowley, Yasir Al‐Rawi, Anthony J. Furlan, Peter McAllister, Mary Hobart, Steven Warach and Jessica Ailani and has published in prestigious journals such as JAMA, Neurology and Stroke.

In The Last Decade

Annika Lindstén

18 papers receiving 312 citations

Peers

Annika Lindstén

PMH

EPIDE

PFM

NEURO

PRM

Tim Cassidy Ireland

Farnaz Amoozegar Canada

Antonio Granato Italy

Qiongzhang Wang China

Gemma Ortega Spain

Sandeep Aggarwal United States

G. J. Luijckx Netherlands

Thomas Lillicrap Australia

Simon Kerr United Kingdom

Monika Zawadka‐Kunikowska Poland

Tim Cassidy Ireland

Annika Lindstén

108 ×0.7

PMH

119 ×1.1

EPIDE

16 ×0.2

PFM

157 ×2.5

NEURO

37 ×0.6

PRM

Citations per year, relative to Annika Lindstén Annika Lindstén (= 1×) peers Tim Cassidy

Countries citing papers authored by Annika Lindstén

Since Specialization

Citations

This map shows the geographic impact of Annika Lindstén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annika Lindstén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annika Lindstén more than expected).

Fields of papers citing papers by Annika Lindstén

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annika Lindstén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annika Lindstén. The network helps show where Annika Lindstén may publish in the future.

Co-authorship network of co-authors of Annika Lindstén

This figure shows the co-authorship network connecting the top 25 collaborators of Annika Lindstén. A scholar is included among the top collaborators of Annika Lindstén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annika Lindstén. Annika Lindstén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hershey, Andrew D., et al.. (2025). Pharmacokinetics and safety of eptinezumab in children and adolescents with migraine. Headache The Journal of Head and Face Pain. 65(9). 1573–1583.

Areberg, Johan, et al.. (2024). Population pharmacokinetics of eptinezumab in paediatric patients with migraine and dose selection for phase 3 paediatric migraine studies. Basic & Clinical Pharmacology & Toxicology. 135(4). 512–522. 1 indexed citations

Cady, Roger, Richard B. Lipton, Dawn C. Buse, et al.. (2022). Optimization of acute medication use following eptinezumab initiation during a migraine attack: post hoc analysis of the RELIEF study. The Journal of Headache and Pain. 23(1). 91–91. 8 indexed citations

McAllister, Peter, Paul Winner, Jessica Ailani, et al.. (2022). Eptinezumab treatment initiated during a migraine attack is associated with meaningful improvement in patient-reported outcome measures: secondary results from the randomized controlled RELIEF study. The Journal of Headache and Pain. 23(1). 22–22. 8 indexed citations

Hauser, Robert A., Antonella Favit, L. Arthur Hewitt, et al.. (2022). Durability of the Clinical Benefit of Droxidopa for Neurogenic Orthostatic Hypotension During 12 Weeks of Open-Label Treatment. Neurology and Therapy. 11(1). 459–469. 5 indexed citations

Ailani, Jessica, Peter McAllister, Paul Winner, et al.. (2022). Rapid resolution of migraine symptoms after initiating the preventive treatment eptinezumab during a migraine attack: results from the randomized RELIEF trial. BMC Neurology. 22(1). 205–205. 14 indexed citations

Hewitt, L. Arthur, et al.. (2021). Characterization of the changes in supine blood pressure with long‐term use of droxidopa in patients with neurogenic orthostatic hypotension. Health Science Reports. 4(1). e227–e227. 1 indexed citations

McAllister, Peter, Jessica Ailani, Lahar Mehta, et al.. (2021). P.027 Efficacy and Safety of Eptinezumab Initiated During a Migraine Attack: Results from the RELIEF Study. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 48(s3). S27–S28.

Winner, Paul, Peter McAllister, Jessica Ailani, et al.. (2021). Efficacy and Safety of Eptinezumab Initiated During a Migraine Attack: Results from the RELIEF Study (1600). Neurology. 96(15_supplement). 1 indexed citations

10.

McAllister, Peter, Paul Winner, Jessica Ailani, et al.. (2021). Eptinezumab Treatment Initiated During a Migraine Attack Prolonged the Time to Next Migraine and Improved HIT-6 Outcomes in the RELIEF Study (1622). Neurology. 96(15_supplement). 1 indexed citations

11.

Winner, Paul, Peter McAllister, Jessica Ailani, et al.. (2021). Effects of Intravenous Eptinezumab vs Placebo on Headache Pain and Most Bothersome Symptom When Initiated During a Migraine Attack. JAMA. 325(23). 2348–2348. 63 indexed citations

12.

Krystal, Andrew D., et al.. (2020). Chronobiologic parameter changes in patients with major depressive disorder and sleep disturbance treated with adjunctive brexpiprazole: An open-label, flexible-dose, exploratory substudy. Journal of Affective Disorders. 278. 288–295. 4 indexed citations

13.

Biederman, Joseph, et al.. (2019). Vortioxetine for attention deficit hyperactivity disorder in adults: A randomized, double-blind, placebo-controlled, proof-of-concept study. Journal of Psychopharmacology. 33(4). 511–521. 18 indexed citations

14.

Bauer, Michael, Nanco Hefting, Annika Lindstén, Mette Krog Josiassen, & Mary Hobart. (2018). A randomised, placebo-controlled 24-week study evaluating adjunctive brexpiprazole in patients with major depressive disorder. Acta Neuropsychiatrica. 31(1). 27–35. 22 indexed citations

15.

Christensen, Michael Cronquist, Ioana Florea, Annika Lindstén, & David S. Baldwin. (2018). Efficacy of vortioxetine on the physical symptoms of major depressive disorder. Journal of Psychopharmacology. 32(10). 1086–1097. 31 indexed citations

16.

Lindstén, Annika, et al.. (2018). Effect of Brexpiprazole on Prolactin. Journal of Clinical Psychopharmacology. 39(1). 13–19. 29 indexed citations

17.

Lindstén, Annika, et al.. (2017). Effect of brexpiprazole on prolactin: an analysis of short- and long-term trials in schizophrenia. European Neuropsychopharmacology. 27. S957–S958. 1 indexed citations

18.

Mori, Etsuro, Kazuo Minematsu, Jyoji Nakagawara, et al.. (2015). Safety and Tolerability of Desmoteplase Within 3 to 9 Hours After Symptoms Onset in Japanese Patients With Ischemic Stroke. Stroke. 46(9). 2549–2554. 13 indexed citations

19.

Warach, Steven, Yasir Al‐Rawi, Anthony J. Furlan, et al.. (2012). Refinement of the Magnetic Resonance Diffusion-Perfusion Mismatch Concept for Thrombolytic Patient Selection. Stroke. 43(9). 2313–2318. 44 indexed citations

20.

Fiebach, Jochen B., Yasir Al‐Rawi, Max Wintermark, et al.. (2012). Vascular Occlusion Enables Selecting Acute Ischemic Stroke Patients for Treatment With Desmoteplase. Stroke. 43(6). 1561–1566. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact